From: The impact of dementia on drug costs in older people: results from the SNAC study
Drug use (%) | Cost/year (SEK) | Drug use (%) | Cost/year (SEK) | Drug use (%) | Cost/year (SEK) | ||||||
Main ATC Group | Non-dementia | Dementia | Non-dementia | Dementia | Community-dwelling | Institution | Community-dwelling | Institution | All | ||
n=3,783a | n=319b | n=3,826 | n=282 | n=4,108 | |||||||
A | Alimentary tract and metabolism | 35.1 | 52.7 | 496 | 789 | 34.7 | 60.3 | 487 | 952 | 36.5 | 519 |
B | Blood and blood forming agents | 29.5 | 47.3 | 330 | 215 | 29.6 | 48.2 | 315 | 394 | 30.9 | 320 |
C | Cardiovascular system | 44.8 | 53.0 | 1,009 | 514 | 44.4 | 57.8 | 997 | 596 | 45.4 | 969 |
D | Dermatologicals | 3.0 | 11.0 | 24 | 66 | 3.0 | 12.1 | 23 | 78 | 3.7 | 27 |
G | Genito urinary system and sex hormones | 22.0 | 13.8 | 348 | 256 | 21.8 | 14.9 | 344 | 296 | 21.3 | 341 |
H | Systemic hormonal preparations, excl. sex hormones | 12.5 | 14.1 | 57 | 40 | 12.3 | 15.6 | 56 | 54 | 12.6 | 56 |
J | General anti-infectives for systemic use | 1.7 | 4.4 | 5 | 12 | 1.7 | 5.7 | 5 | 13 | 1.9 | 6 |
L | Antineoplastic and immunomodulating agents | 2.3 | 1.3 | 245 | 94 | 3.0 | 1.1 | 245 | 68 | 2.2 | 233 |
M | Musculo-skeletal system | 17.1 | 8.5 | 261 | 137 | 16.8 | 11.3 | 260 | 132 | 16.4 | 251 |
N | Nervous system | 34.4 | 67.0 | 585 | 3,202 | 33.8 | 79.8 | 607 | 3,295 | 37.0 | 792 |
P | Antiparasitic products | 0.6 | 1.6 | 127 | 458 | 0.7 | 1.4 | 121 | 584 | 0.7 | 152 |
R | Respiratory system | 12.3 | 13.2 | 274 | 256 | 12.0 | 16.7 | 266 | 344 | 12.3 | 272 |
S | Sensory organs | 6.7 | 8.4 | 47 | 108 | 6.6 | 11.7 | 44 | 155 | 6.9 | 52 |
V | Various | 0.2 | 0 | 3 | 0 | 0.2 | 0 | 3 | - | 0.1 | 2 |
Total* | 81.7c | 79.8c | 3,810 | 6,147 | 80.9c | 88.4c | 3,773 | 6,961 | 81.4c | 3,992 |